First advanced therapy, ChondroCelect, OKd in EU for knee damage
This article was originally published in Scrip
Executive Summary
A cell-based medicine for repairing knee damage has become the first product to be recommended for approval by the European Medicines Agency under the EU's new advanced therapy regulatory framework.